Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

CHRS holding history

Coherus Oncology, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CHRS overviewAll 13F holders of CHRSFull Q2 2026 holdings

Shares (Q2 2026)
22,172
Value
$31.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CHRS by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202622,172$31.0K<0.1%+472+2.2%AddedHolders
Q1 202621,700$36.7K<0.1%−3,018−12.2%ReducedHolders
Q4 202524,718$35.1K<0.1%+6,583+36.3%AddedHolders
Q3 202518,135$29.7K<0.1%−3,613−16.6%ReducedHolders
Q2 202521,748$15.9K<0.1%−2,583−10.6%ReducedHolders
Q1 202524,331$19.6K<0.1%−7,004−22.4%ReducedHolders
Q4 202431,335$43.2K<0.1%+3,504+12.6%AddedHolders
Q3 202427,831$28.9K<0.1%+6,688+31.6%AddedHolders
Q2 202421,143$36.6K<0.1%−5,520−20.7%ReducedHolders
Q1 202426,663$63.7K<0.1%+3,028+12.8%AddedHolders
Q4 202323,635$78.7K<0.1%+4,494+23.5%AddedHolders
Q3 202319,141$71.6K<0.1%+1,299+7.3%AddedHolders
Q2 202317,842$76.2K<0.1%+2,020+12.8%AddedHolders
Q1 202315,822$108.2K<0.1%−1,971−11.1%ReducedHolders
Q4 202217,793$140.9K<0.1%+1,381+8.4%AddedHolders
Q3 202216,412$158.0K<0.1%+264+1.6%AddedHolders
Q2 202216,148$117.0K<0.1%−6,260−27.9%ReducedHolders
Q1 202222,408$289.0K<0.1%−4,602−17.0%ReducedHolders
Q4 202127,010$432.0K<0.1%+819+3.1%AddedHolders
Q3 202126,191$421.0K<0.1%−5,879−18.3%ReducedHolders
Q2 202132,070$444.0K<0.1%+4,390+15.9%AddedHolders
Q1 202127,680$404.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.